Pitfalls in the diagnosis of cervical intraepithelial neoplasia 1

Journal of Lower Genital Tract Disease

Volumn 8, Issue 3, 2004, Pages 181-187

  Elit, Laurie M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

CIN 1; Low grade dysplasia

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16;

CANCER DIAGNOSIS; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELECTROSURGERY; FEMALE; GENETIC ANALYSIS; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MEDLINE; OBSERVER VARIATION; PATIENT REFERRAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 3042858942     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200407000-00004     Document Type: Review

References (25)

1. Shafi MI, Luesley DM, Jordan JA, Dunn JA, Rollason TP, Yates M. Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynecol 1997;104:590-4.
2. Hall S, Wu TC, Soudi N, Sherman ME. Low-grade squamous intraepithelial lesions: cytologic predictors of biopsy confirmation. Diagn Cytopathol 1994;10:3-9.
3. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the Randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-7.
4. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2004;188:1393-400.
5. Lee SSN, Collins RJ, Pun TC, Cheng DKL, Ngan HYS. Conservative treatment of low grade squamous intraepithelial lesions (LSIL) of the cervix. Int J Gynecol Obstet 1998;60: 35-40.
6. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-12.
7. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285:1500-5.
8. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Post-menopausal squamous atypia: a spectrum including "pseudo-koilocytosis." Mod Pathol 1995;8:408-12.
9. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12: 186-92.
10. Elit L, McLachlin CM, Kirk ME, Smith J, Townsend D, Carey M, et al. Management of colposcopy patients with biopsy proven CIN 1. J Lower Genital Tract Dis 1999;3:1-5.
11. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
12. Furber SE, Weisberg E, Simpson JM. Progression and regression of low-grade epithelial abnormalities of the cervix. Aust N Z J Obstet Gynaecol 1997;37:107-11.
13. Falls RK. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol 1999;181:278-82.
14. Tay SK. High long-term cure rate justifies routine treatment of cervical intraepithelial neoplasia grade 1. Aust N Z J Obstet Gynaecol 1995;35:192-5.
15. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2004;188:1401-5.
16. Bollen LJM, Tjong-a-hung SP, Van Der Velden J, Mol BW, Boer K, Ten Kate FJW, et al. Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia. Sex Transm Dis 1997;24:456-60.
17. Montz FJ. Impact of therapy for cervical intraepithelial neoplasia on fertility. Am J Obstet Gynecol 1996;175: 1129-36.
18. Richart RM, Wight TC. Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 1993;71:1413-21.
19. Leung M, Osborne R. A survey of colposcopic practice in Ontario (abstract). Soc Obstet Gynecol Can 1998;O0087-SCC.
20. Hartz LE, Fenaughty AM. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet Gynecol 2001;98: 674-9.
21. Stoler MH. Human papillomavirus biology and cervical neoplasia. Arch Pathol Lab Med 2003;127:935-1030.
22. Crum CP, Abbott DW, Quade BJ. Cervical cancer screening: from the Papanicolaou smear to the vaccine era. J Clin Oncol 2003;21(10 Suppl):224-30.
23. Pirog EC, Baergen RN, Soslow RA, Tam D, DeMattia AE, Chen YT, et al. Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 2002;26:70-5.
24. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, et al. P16(INK)4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep TM smears. J Clin Pathol 2003;56:56-63.
25. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al. P16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26: 1389-99.